Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "I wouldn’t go and sell Dr Reddy's Laboratories but it is not a buying opportunity. It has to start giving us the message that the decline in this stock is over. We are getting some of this message, it is not enough, let it stay here for days and weeks and then only it should be reconsidered for buying. In any case, I would not go and sell it. A strong stock remains a strong stock for quite some time."Sun Pharma has the same story, a gap down, repeated gap downs, breakdowns from multiple support levels and then making news lows. So Dr Reddy's at least is giving us a sense that the worst maybe over. Sun Pharma is not giving that sense also, so you just stay away from it," he added.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!